RT Journal Article
SR Electronic
T1 Assent as an ethical imperative in the treatment of ADHD
JF Journal of Medical Ethics
JO J Med Ethics
FD BMJ Publishing Group Ltd and Institute of Medical Ethics
SP 977
OP 981
DO 10.1136/medethics-2014-102166
VO 41
IS 12
A1 Anson J Koshy
A1 Dominic A Sisti
YR 2015
UL http://jme.bmj.com/content/41/12/977.abstract
AB The American Academy of Paediatrics endorses obtaining assent when prescribing medications for attention-deficit/hyperactivity disorder (ADHD) in older children whenever possible. Studies indicate the concept of assent may not be well understood by clinicians, possibly effecting effective and widespread implementation. We argue that though the concept of assent continues to evolve, it is critical in the context of patient-centred care, shared decision-making and in supporting minors’ transition to adulthood. Based on the principle of respect for young persons, we argue that obtaining assent is an ethical imperative when prescribing medication for ADHD. We highlight the instrumental benefits of obtaining assent in the paediatric clinical encounter when prescribing medications for treatment of ADHD.